Mirikizumab (Omvoh™) for ulcerative colitis.

Autor:	Hammerhøj A; Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Boye TL; Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Langholz E; Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Herlev, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Nielsen OH; Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Herlev, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address: ole.haagen.nielsen@regionh.dk.
Jazyk:	angličtina
Zdroj:	Trends in pharmacological sciences [Trends Pharmacol Sci] 2024 Mar; Vol. 45 (3), pp. 281-282. Date of Electronic Publication: 2024 Jan 22.
DOI:	10.1016/j.tips.2024.01.001
Abstrakt:	Competing Interests: Declaration of interests No interests are declared.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect